Free Trial

Adaptimmune Therapeutics (ADAP) Income Statement & Balance Sheet

Adaptimmune Therapeutics logo
$0.56 -0.02 (-3.88%)
As of 02:43 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Adaptimmune Therapeutics Income Statement, Balance Sheet and Cash Flow Statement



This page (NASDAQ:ADAP) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners